Whether you are a new T1D Family, a TrialNet participant, a healthcare provider, or a researcher — you'll find resources here.
We’re here to help you after a new T1D diagnosis. Get answers to frequently asked questions and learn about clinical studies testing ways to maintain insulin production.
While you wait for screening results, get answers to your questions, find out about next steps, and learn more about TrialNet’s Pathway to Prevention.
Your T1D families are important to you. Learn how easy it is to connect your patients with world-class T1D research.
The University of Florida (UF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Desmond Schatz, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Augusta University Satellite Clinic
6105 Peachtree Dunwoody Rd, Atlanta, GA 30328
1120 15th St., Augusta, GA 30912
Medical University of South Carolina
96 Jonathan Lucas St, Charleston, SC 29425
University of South Carolina, School of Medicine
9 Medical Park Drive Suite 230A, Columbia, SC 29203
GHS - Pediatric Endocrinology
200 Patewood Drive, Suite A320, Greenville, SC 29615
877 West Faris Road, Greenville, SC 29605
Nemours Childrens Clinic-Jacksonville
807 Children's Way, Jacksonville, FL 32207
East Tennessee Childrens Hospital
2100 Clinch Avenue, Children's Hospital Medical Office Building, Knoxville, TN 37916
Nemours Childrens Clinic-Orlando
6900 Lake Nona Blvd, Orlando, FL 32827
Arnold Palmer Pediatric Endo
89 W. Copeland Drive, 2nd Floor, Orlando, FL 32806
Translational Research Institute for Metabolism and Diabetes
601 E. Rollins, Box 207, Orlando, FL 32803
Nemours Children's Clinic-Pensacola
5153 N 9th Ave, Pensacola, FL 32504
Hanson Clinical Research Center
21216 Olean Blvd. Suite 8, Port Charlotte, FL 33952
WakeMed Children's Diabetes and Endocrinology
23 Sunnybrook Rd,, Raleigh, NC 27511
Larry C. Deeb MD
2804 Remington Green Circle, Suite 1, Tallahassee, FL 32308
If you have a relative with T1D, you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for Pathway to Prevention screening to determine your risk of developing T1D.
TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression.
We tested the drug teplizumab to see if it could delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production.
We are testing the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (stage 3). HCQ is already used to reduce symptoms and progression of other autoimmune diseases, such as rheumatoid arthritis and lupus. This is the first study to see if it can prevent or delay T1D.
Once your study ends, we're still here for you. Participant monitoring and continued involvement helps us learn more about T1D.